Literature DB >> 23316031

Quantitative analysis of acetaminophen and its primary metabolites in small plasma volumes by liquid chromatography-tandem mass spectrometry.

Thomas Gicquel1, Jacinthe Aubert, Sylvie Lepage, Bernard Fromenty, Isabelle Morel.   

Abstract

A fast and sensitive liquid chromatography-tandem mass spectrometry (LC-MS-MS) method was developed and validated for the simultaneous determination of acetaminophen (APAP) and its glucuronide and sulfate metabolites (APAP-GLU and APAP-SUL) in small plasma volumes. This method included a simple step of sample preparation and a chromatographic separation on an LC-MS-MS system equipped with an electrospray ionization source and a tandem triple quadrupole mass spectrometer in multiple reaction monitoring mode. The analytes and internal standard, APAP deuterated analog, were separated on a C18 column (3.0 µm, 2.1 × 100 mm), using aqueous 1% formic acid and methanol (80:20, v/v) as the mobile phase. The LC-MS-MS method was validated for accuracy, precision, linearity, extraction efficiency, process efficiency and matrix effect. Calibration curves were obtained by fortifying drug-free plasma and ranges of linearity were set between 0.25-20 mg/L. The mean correlation coefficients, r², were >0.99 for APAP and its metabolites. The inter-day and intra-day precision values were less than 11.75 and 13.03%, respectively, at the lower limit of quantification concentration. The usability of the method was demonstrated by studying APAP metabolism in C57BL/6J wild-type and obese ob/ob female mice, in which only small plasma volumes were available. The results showed that APAP glucuronidation was enhanced in obese mice, suggesting that changes in APAP metabolism could modify its toxicity in obesity and related fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23316031     DOI: 10.1093/jat/bks139

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  6 in total

1.  The novel, potent and highly selective 5-HT4 receptor agonist YH12852 significantly improves both upper and lower gastrointestinal motility.

Authors:  Eun Jeong Jeong; Soo Yong Chung; Han Na Hong; Se-Woong Oh; Jae Young Sim
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

2.  Alterations in circadian rhythms aggravate Acetaminophen-induced liver injury in mice by influencing Acetaminophen metabolization and increasing intestinal permeability.

Authors:  Kun Zhang; Xiude Fan; Xiaoyun Wang; Xiaoge Zhang; Lu Zeng; Na Li; Qunying Han; Yi Lv; Zhengwen Liu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Performance evaluation of five commercial assays for detection of acetaminophen.

Authors:  Bao-Yum Chan; Hing-Man Tsang; Candy Wai-Yan Ng; William Hin-Wing Ling; Daniel Cheuk-Wa Leung; Hencher Han-Chih Lee; Chloe Miu Mak
Journal:  J Clin Lab Anal       Date:  2018-10-04       Impact factor: 2.352

4.  A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen.

Authors:  Anaïs Michaut; Dounia Le Guillou; Caroline Moreau; Simon Bucher; Mitchell R McGill; Sophie Martinais; Thomas Gicquel; Isabelle Morel; Marie-Anne Robin; Hartmut Jaeschke; Bernard Fromenty
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

5.  Glucosamine-paracetamol spray-dried solid dispersions with maximized intrinsic dissolution rate, bioavailability and decreased levels of in vivo toxic metabolites.

Authors:  Ahmed Mahmoud Abdelhaleem Ali; Ahmed Khames; Majed Mansour Alrobaian; Mohammad Hamaidi; Mohammed As Abourehab
Journal:  Drug Des Devel Ther       Date:  2018-09-21       Impact factor: 4.162

6.  Quantitation of paracetamol by liquid chromatography-mass spectrometry in human plasma in support of clinical trial.

Authors:  Richard Kin-Ting Kam; Michael Ho-Ming Chan; Hiu-Ting Wong; Aniruddha Ghose; Arjen M Dondorp; Katherine Plewes; Joel Tarning
Journal:  Future Sci OA       Date:  2018-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.